These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6146287)

  • 21. Effect of cimetidine and carbenoxolone on cysteamine-induced ulcers: a study of gastric mucosal histamine and histamine formation capacity in rat.
    Man WK; Boesby S; Mendez-Diaz R; Spencer J
    Agents Actions; 1984 Dec; 15(5-6):467-73. PubMed ID: 6532172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 23. Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.
    Di Mario F; Battaglia G; Leandro G; Grasso G; Vianello F; Vigneri S
    Dig Dis Sci; 1996 Jun; 41(6):1108-31. PubMed ID: 8654142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H2-receptor antagonists: development and application.
    Feldman S
    N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG; de Looze SM; Bender W; Labs R
    Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional antacid does not increase the effect of cimetidine in gastric ulcer disease.
    Rune SJ; Jensen KG; Wulff HR; Bendtsen F; Lindskov J; Mejer J; Højlund M; Nissen VR; Willumsen L; Agner E
    Scand J Gastroenterol; 1984 Jan; 19(1):56-8. PubMed ID: 6369522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current aspects of the therapy of gastroduodenal peptic ulcer].
    Castro Lde P
    Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for peptic ulcer.
    Clark CG; Wyllie JH
    World J Surg; 1977 Jan; 1(1):3-7. PubMed ID: 17229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment of gastric and duodenal ulcer.
    Baron JH
    Klin Wochenschr; 1976 Oct; 54(19):915-25. PubMed ID: 790009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Scheen AJ
    Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
    Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
    Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.
    Young MD; Frank WO; Dickson BD; Peace KP; Braverman A; Mounce W
    Aliment Pharmacol Ther; 1989 Feb; 3(1):47-57. PubMed ID: 2577482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peptic ulcer: new aspects of conservative therapy].
    Bernoulli R
    Schweiz Med Wochenschr; 1977 May; 107(18):618-22. PubMed ID: 17157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial.
    Barbara L; Belsasso E; Blasi A; Caenazzo E; Di Febo G; Di Mario F; Giorgi-Conciato M; Marletta F; Miglioli M; Petrillo M; Salvagnini M; Scalabrin G
    Scand J Gastroenterol Suppl; 1979; 57():21-4. PubMed ID: 396653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Conservative treatment of gastric ulcer].
    Bretzke G
    Z Arztl Fortbild (Jena); 1981 Feb; 75(3):93-5. PubMed ID: 6116361
    [No Abstract]   [Full Text] [Related]  

  • 38. [Conservative therapy of peptic ulcer].
    Clémençon GH
    Schweiz Med Wochenschr; 1980 Oct; 110(41):1474-82. PubMed ID: 6106967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine H2-receptor antagonists in the treatment of duodenal ulcers.
    Bank S; Barbezat GO; Novis BH; Tim LO; Odes HS; Helman C; Narunsky L; Duys PJ; Marks IN
    S Afr Med J; 1976 Oct; 50(44):1781-5. PubMed ID: 11564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
    Alekseenko SA; Timoshin SS
    Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.